Special items: Ovarian Cancer and Us blog best viewed in Firefox

Thursday, January 29, 2009

Pegylated liposomal doxorubicin (Caelyx) in patients with advanced ovarian cancer: results of a German multicenter observational study

SpringerLink - Journal Article

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.